Study says switch in arthritis drugs may help

06/25/2004 | Reuters Health

A small study reported in the Journal of Rheumatology says switching from one rheumatoid arthritis drug to another within the medication class called tumor necrosis factor (TNF) inhibitors can improve the outcome for patients. Doctors working with TNF inhibitors Remicade and Enbrel studied 20 patients switching from Enbrel to Remicade and another group of 73 receiving Remicade with no prior TNF inhibitor therapy and found both groups showed significant improvement.

View Full Article in:

Reuters Health

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA